2017 Peer Reviewers.
- Published in:
- Clinical Trials, 2018, v. 15, n. 1, p. 112, doi. 10.1177/1740774518756566
- Publication type:
- Article
Works matching IS 17407745 AND DT 2018 AND VI 15 AND IP 1
Results: 16
1
2
Rejoinder.
- Published in:
- Clinical Trials, 2018, v. 15, n. 1, p. 25, doi. 10.1177/1740774517746638
- By:
- Publication type:
- Article
3
Rejoinder.
- Published in:
- Clinical Trials, 2018, v. 15, n. 1, p. 27, doi. 10.1177/1740774517746629
- By:
- Publication type:
- Article
4
TwiC or treat? Are trials within cohorts ethically defensible?
- Published in:
- Clinical Trials, 2018, v. 15, n. 1, p. 21, doi. 10.1177/1740774517746622
- By:
- Publication type:
- Article
5
Innovative approaches to informed consent for randomized clinical trials: Identifying the ethical challenges.
- Published in:
- Clinical Trials, 2018, v. 15, n. 1, p. 17, doi. 10.1177/1740774517746621
- By:
- Publication type:
- Article
6
Ethics and practice of Trials within Cohorts: An emerging pragmatic trial design.
- Published in:
- Clinical Trials, 2018, v. 15, n. 1, p. 9, doi. 10.1177/1740774517746620
- By:
- Publication type:
- Article
7
Just-in-time consent: The ethical case for an alternative to traditional informed consent in randomized trials comparing an experimental intervention with usual care.
- Published in:
- Clinical Trials, 2018, v. 15, n. 1, p. 3, doi. 10.1177/1740774517746610
- By:
- Publication type:
- Article
8
A systematic review and development of a classification framework for factors associated with missing patient-reported outcome data.
- Published in:
- Clinical Trials, 2018, v. 15, n. 1, p. 95, doi. 10.1177/1740774517741113
- By:
- Publication type:
- Article
9
Factors associated with reporting results for pulmonary clinical trials in ClinicalTrials.gov.
- Published in:
- Clinical Trials, 2018, v. 15, n. 1, p. 87, doi. 10.1177/1740774517740352
- By:
- Publication type:
- Article
10
A systematic review of Federal Drug Administration Docket for community consultation and public disclosure in exception from informed consent trials.
- Published in:
- Clinical Trials, 2018, v. 15, n. 1, p. 29, doi. 10.1177/1740774517737318
- By:
- Publication type:
- Article
11
Time to institutional review board approval with local versus central review in a multicenter pragmatic trial.
- Published in:
- Clinical Trials, 2018, v. 15, n. 1, p. 107, doi. 10.1177/1740774517735536
- By:
- Publication type:
- Article
12
PrEP Chicago: A randomized controlled peer change agent intervention to promote the adoption of pre-exposure prophylaxis for HIV prevention among young Black men who have sex with men.
- Published in:
- Clinical Trials, 2018, v. 15, n. 1, p. 44, doi. 10.1177/1740774517730012
- By:
- Publication type:
- Article
13
Multiplicity-adjusted semiparametric benefiting subgroup identification in clinical trials.
- Published in:
- Clinical Trials, 2018, v. 15, n. 1, p. 75, doi. 10.1177/1740774517729167
- By:
- Publication type:
- Article
14
Neurobiological mechanisms of exercise and psychotherapy in depression: The SPeED study—Rationale, design, and methodological issues.
- Published in:
- Clinical Trials, 2018, v. 15, n. 1, p. 53, doi. 10.1177/1740774517729161
- By:
- Publication type:
- Article
15
Characteristics and trends of clinical trials funded by the National Institutes of Health between 2005 and 2015.
- Published in:
- Clinical Trials, 2018, v. 15, n. 1, p. 65, doi. 10.1177/1740774517727742
- By:
- Publication type:
- Article
16
Use of an android phone application for automated text messages in international settings: A case study in an HIV clinical trial in St. Petersburg, Russia.
- Published in:
- Clinical Trials, 2018, v. 15, n. 1, p. 36, doi. 10.1177/1740774517726067
- By:
- Publication type:
- Article